Randomized controlled trial about the impact of oral antimicrobial prophylaxis on surgical site infection in laparoscopic colorectal surgery
Phase 3
- Conditions
- Patients undergoing elective laparoscopic colorectal surgery
- Registration Number
- JPRN-UMIN000019339
- Lead Sponsor
- Cancer Institute Hospital of Japanese Foundation for Cancer Research, Department of Gastroenterological surgery
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
Not provided
Exclusion Criteria
1)ileus 2)synchronous resection of other major organs 3)Patients who need antibiotics for other infectious diseases. 4)Patients who have undergone antibiotic administration 2 weeks before the surgery. 5)Patients with severe liver dysfunction 6)Patients with severe renal impairment 7)Patients with severe cardiac dysfunction 8)Patients with severe pulmonary dysfunction 9)Pregnancy or suspicion of pregnancy 10)lactating women 11)Patients who are considered unsuitable for the doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary endpoint is the incidence of overall surgical site infection.
- Secondary Outcome Measures
Name Time Method The secondary endpoints are the incidence of incisional site infections, organ/space infections, and enterocolitis.